Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?

Tekijä Enjoji, Munechika, Nakamuta, Makoto
Julkaistu 2010

Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol

Tekijä Enjoji, Munechika, Yasutake, Kenichiro, Kohjima, Motoyuki, Nakamuta, Makoto
Julkaistu 2012

Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments

Tekijä Enjoji, Munechika, Kohjima, Motoyuki, Kotoh, Kazuhiro, Nakamuta, Makoto
Julkaistu 2012

Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE

Tekijä Nakamuta, Makoto, Kotoh, Kazuhiro, Enjoji, Munechika, Nawata, Hajime
Julkaisussa World J Gastroenterol (2005)

Transforming Growth Factor‐α Induces the Differentiation of Sarcomatoid Cholangiocarcinoma Cells

Tekijä Enjoji, Munechika, Nakashima, Manabu, Nakamuta, Makoto, Nawata, Hajime
Julkaisussa Jpn J Cancer Res (2000)

A new treatment strategy for acute liver failure

Tekijä Kotoh, Kazuhiro, Kato, Masaki, Kohjima, Motoyuki, Nakamuta, Makoto, Enjoji, Munechika
Julkaistu 2010

Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma

Tekijä Nakamuta, Makoto, Morizono, Shusuke, Kohjima, Motoyuki, Kotoh, Kazuhiro, Enjoji, Munechika
Julkaisussa World J Gastroenterol (2005)

A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: A r...

Tekijä Kotoh, Kazuhiro, Enjoji, Munechika, Kato, Masaki, Kohjima, Motoyuki, Nakamuta, Makoto, Takayanagi, Ryoichi
Julkaistu 2008

Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake

Tekijä Yasutake, Kenichiro, Kohjima, Motoyuki, Nakashima, Manabu, Kotoh, Kazuhiro, Nakamuta, Makoto, Enjoji, Munechika
Julkaistu 2012

Dietary habits and behaviors associated with nonalcoholic fatty liver disease

Tekijä Yasutake, Kenichiro, Kohjima, Motoyuki, Kotoh, Kazuhiro, Nakashima, Manabu, Nakamuta, Makoto, Enjoji, Munechika
Julkaistu 2014

Novel serum tumor marker, RCAS1, in pancreatic diseases

Tekijä Yamaguchi, Koji, Enjoji, Munechika, Nakashima, Manabu, Nakamuta, Makoto, Watanabe, Takashi, Tanaka, Masao
Julkaisussa World J Gastroenterol (2005)

Local recurrence is an important prognostic factor of hepatocellular carcinoma

Tekijä Arimura, Eiichirou, Kotoh, Kazuhiro, Nakamuta, Makoto, Morizono, Shusuke, Enjoji, Munechika, Nawata, Hajime
Julkaisussa World J Gastroenterol (2005)

Fenofibrate for patients with asymptomatic primary biliary cirrhosis

Tekijä Dohmen, Kazufumi, Mizuta, Toshihiko, Nakamuta, Makoto, Shimohashi, Naoya, Ishibashi, Hiromi, Yamamoto, Kyosuke
Julkaisussa World J Gastroenterol (2004)

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells

Tekijä Kohjima, Motoyuki, Enjoji, Munechika, Higuchi, Nobito, Kotoh, Kazuhiro, Kato, Masaki, Takayanagi, Ryoiichi, Nakamuta, Makoto
Julkaistu 2007

Serum albumin is present at higher levels in alcoholic liver cirrhosis as compared to HCV-related cirrhosis

Tekijä KOTOH, KAZUHIRO, FUKUSHIMA, MARIE, HORIKAWA, YUKI, YAMASHITA, SHINSAKU, KOHJIMA, MOTOYUKI, NAKAMUTA, MAKOTO, ENJOJI, MUNECHIKA
Julkaistu 2012

High relative fat-free mass is important for maintaining serum albumin levels in patients with compensated liver cirrhosis

Tekijä Kotoh, Kazuhiro, Nakamuta, Makoto, Fukushima, Marie, Matsuzaki, Chitose, Enjoji, Munechika, Sakai, Hironori, Nawata, Hajime
Julkaisussa World J Gastroenterol (2005)

Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma

Tekijä Enjoji, Munechika, Morizono, Shusuke, Kotoh, Kazuhiro, Kohjima, Motoyuki, Miyagi, Yuzuru, Yoshimoto, Tsuyoshi, Nakamuta, Makoto
Julkaisussa World J Gastroenterol (2005)

Scattered and rapid intrahepatic recurrences after radio frequency ablation for hepatocellular carcinoma

Tekijä Kotoh, Kazuhiro, Enjoji, Munechika, Arimura, Eiichirou, Morizono, Shusuke, Kohjima, Motoyuki, Sakai, Hironori, Nakamuta, Makoto
Julkaisussa World J Gastroenterol (2005)

A Case of Suspicious Allergic Reaction to Peracetic Acid Following Endoscopy

Tekijä Harada, Naohiko, Hirowatari, Manami, Ihara, Eikichi, Ishihara, Etsuko, Inoue, Mitsuko, Miyamura, Tomoya, Nakamuta, Makoto
Julkaisussa Clin Endosc (2020)

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

Tekijä Kotoh Kazuhiro, Kato Masaki, Kohjima Motoyuki, Machida Kazuyuki, Enjoji Munechika, Matsunaga Kazuhisa, Nakashima Manabu, Nakamuta Makoto
Julkaistu 2010-03-01